This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Pawlotsky, J. M. Articles by Dussaix, E. Search for Related Content PubMed PubMed Citation Articles by Pawlotsky, J. M. Articles by Dussaix, E.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, Jul 1997, 1734-1739, Vol 35, No. 7
Copyright © 1997 by the American Society for Microbiology. All rights reserved.

Serological determination of hepatitis C virus genotype: comparison with a standardized genotyping assay

JM Pawlotsky, L Prescott, P Simmonds, C Pellet, P Laurent-Puig, C Labonne, F Darthuy, J Remire, J Duval, C Buffet, JP Etienne, D Dhumeaux and E Dussaix
Department of Bacteriology and Virology, Hopital Henri Mondor, Universite Paris XII, Creteil, France. pawlotsky@univ-paris12.fr

In patients with chronic hepatitis C, determination of hepatitis C virus (HCV) genotype could be routinely run in the future to tailor treatment schedules. The suitabilities of two versions of a serological, so-called serotyping assay (Murex HCV Serotyping Assay version 1-3 [SA1-3] and Murex HCV Serotyping Assay version 1-6 [SA1-6]; Murex Diagnostics Ltd.), based on the detection of genotype-specific antibodies directed to epitopes encoded by the NS4 region of the genome, for the routine determination of HCV genotypes were studied. The results were compared with those of a molecular biology-based genotyping method (HCV Line Probe Assay [INNO-LiPA HCV]; Innogenetics S.A.), based on hybridization of PCR products onto genotype-specific probes designed in the 5' noncoding region of the genome, obtained with pretreatment serum samples from 88 patients with chronic hepatitis C eligible for interferon therapy. Definitive genotyping was performed by sequence analysis of three regions of the viral genome in all samples with discrepant typing results found among at least two of the three assays studied. In all instances, sequence analysis confirmed the result of the INNO-LiPA HCV test. The sensitivity of SA1-3 was 75% relative to the results obtained by the genotyping assay. The results were concordant with those of genotyping for 92% of the samples typeable by SA1-3. The sensitivity of SA1-6 was 89% relative to the results obtained by the genotyping assay. The results were concordant with those of genotyping for 94% of the samples typeable by SA1-6. Overall, SA1-6 had increased sensitivity relative to SA1-3 but remained less sensitive than the genotyping assay on the basis of PCR amplification of HCV RNA. Cross-reactivities between different HCV genotypes could be responsible for the mistyping of 8 (SA1-3) and 6% (SA1-6) of the samples. Subtyping of 1a and 1b is still not possible with the existing peptides, but discriminating between subtypes may not be necessary for routine use.

This article has been cited by other articles:

• Henquell, C., Cartau, C., Abergel, A., Laurichesse, H., Regagnon, C., De Champs, C., Bailly, J.-L., Peigue-Lafeuille, H. (2004). High Prevalence of Hepatitis C Virus Type 5 in Central France Evidenced by a Prospective Study from 1996 to 2002. J. Clin. Microbiol. 42: 3030-3035 [Abstract] [Full Text]  
• Gault, E., Soussan, P., Morice, Y., Sanders, L., Berrada, A., Rogers, B., Deny, P. (2003). Evaluation of a New Serotyping Assay for Detection of Anti-Hepatitis C Virus Type-Specific Antibodies in Serum Samples. J. Clin. Microbiol. 41: 2084-2087 [Abstract] [Full Text]  
• Richter, S. S. (2002). Laboratory Assays for Diagnosis and Management of Hepatitis C Virus Infection. J. Clin. Microbiol. 40: 4407-4412 [Full Text]  
• Schroter, M., Zollner, B., Schafer, P., Landt, O., Lass, U., Laufs, R., Feucht, H.-H. (2002). Genotyping of Hepatitis C Virus Types 1, 2, 3, and 4 by a One-Step LightCycler Method Using Three Different Pairs of Hybridization Probes. J. Clin. Microbiol. 40: 2046-2050 [Abstract] [Full Text]  
• Ross, R. S., Viazov, S., Thormahlen, M., Bartz, L., Tamm, J., Rautenberg, P., Roggendorf, M., Deister, A., and the Incident Investigation Team, (2002). Risk of Hepatitis C Virus Transmission From an Infected Gynecologist to Patients: Results of a 7-Year Retrospective Investigation. Arch Intern Med 162: 805-810 [Abstract] [Full Text]  
• Dufour, D. R., Lott, J. A., Nolte, F. S., Gretch, D. R., Koff, R. S., Seeff, L. B. (2000). Diagnosis and Monitoring of Hepatic Injury. I. Performance Characteristics of Laboratory Tests. Clin. Chem. 46: 2027-2049 [Abstract] [Full Text]  
• Schröter, M., Feucht, H.-H., Schäfer, P., Zöllner, B., Laufs, R. (1999). Serological Determination of Hepatitis C Virus Subtypes 1a, 1b, 2a, 2b, 3a, and 4a by a Recombinant Immunoblot Assay. J. Clin. Microbiol. 37: 2576-2580 [Abstract] [Full Text]  
• Rodriguez-Lopez, M, Riezu-Boj, J., Ruiz, M, Berasain, C, Civeira, M., Prieto, J, Borras-Cuesta, F (1999). Immunogenicity of variable regions of hepatitis C virus proteins: selection and modification of peptide epitopes to assess hepatitis C virus genotypes by ELISA. J. Gen. Virol. 80: 727-738 [Abstract]  
• Sreevatsan, S., Bookout, J. B., Ringpis, F. M., Pottathil, M. R., Marshall, D. J., De Arruda, M., Murvine, C., Fors, L., Pottathil, R. M., Barathur, R. R. (1998). Algorithmic Approach to High-Throughput Molecular Screening for Alpha Interferon-Resistant Genotypes in Hepatitis C Patients. J. Clin. Microbiol. 36: 1895-1901 [Abstract] [Full Text]